Trial intelligence / Profile preview

Topical Thrombin (Human) Grifols for Hemostasis in Surgery

NCT02014402Phase 2Completed

Sponsor
Grifols
Start
Dec 2013
Primary completion
Nov 2015
Modality
Therapeutic Enzymes
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of thrombin in postoperative hemorrhage (2 arms), sponsored by Grifols. Primary endpoint: Proportion of Subjects Achieving Hemostasis by Five Minutes After Treatment Start at the TBS at 5 minutes. Started Dec 2013; status: completed.

02

Drugs

thrombin
03

Conditions

postoperative hemorrhage

Beyond the preview

Go deeper on NCT02014402.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02014402.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call